The clinical phenotype of c.65T>C, p.Leu22Pro SMAD9 HBM has many features in common with that of LRP5 HBM but lacks the deleterious features that characterize SOST HBM (sclerosteosis). Here, LRP5 is linked to sclerosteosis.